The Relationship Between Gait and Severity of Femoroacetabular Impingement
The Relationship Between Spatiotemporal Gait Parameters and Imaging-based Characteristics of Femoroacetabular Impingement (FAI) in Symptomatic Individuals
1 other identifier
observational
25
1 country
1
Brief Summary
In this study, the spatiotemporal gait parameters of symptomatic femoroacetabular impingement (FAI) patients scheduled for hip arthroscopy are evaluated. Radiological measurements, including the Alpha angle (AA), Lateral Center-Edge Angle (LCEA), and Kellgren-Lawrence (KL) osteoarthritis classification, are recorded from patient files. The relationship between these radiological measurements and walking parameters is assessed. Additionally, the spatiotemporal gait parameters of FAI patients are compared with those of a healthy control group. Walking assessments provide valuable insights into how Femoroacetabular Impingement (FAI) affects movement and aid in evaluating treatment outcomes. Research indicates that individuals with FAI experience reduced hip motion and slower walking speeds. By analyzing spatiotemporal gait parameters-such as gait velocity, cadence, step length, and vertical center of mass-the impact of FAI on walking can be better understood, leading to the development of targeted treatment strategies. The goal is to explore the correlation between these gait parameters and imaging-based FAI characteristics in affected individuals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2022
CompletedFirst Submitted
Initial submission to the registry
July 29, 2024
CompletedFirst Posted
Study publicly available on registry
August 2, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2024
CompletedAugust 2, 2024
July 1, 2024
2.7 years
July 29, 2024
July 31, 2024
Conditions
Outcome Measures
Primary Outcomes (4)
Gait velocity
Gait velocity, also known as walking speed, is a crucial parameter in spatiotemporal gait analysis. It refers to the rate at which an individual walks over a given distance and is typically measured in meters per second (m/s).
Baseline
Cadence
Cadence refers to the number of steps a person takes per minute while walking.
Baseline
Step length
Step length refers to the distance covered between two consecutive footfalls of opposite feet.
Baseline
Vertical center of mass
The vertical center of mass refers to the vertical position of the body's center of mass during walking. It is the point where the body's mass is considered to be concentrated and it fluctuates as the person moves.
Baseline
Study Arms (2)
Patient with Femoroacetabular Impingement
Symptomatic femoroacetabular impingement patients scheduled for hip arthroscopy
Control group
Healthy indivicuals without Femoroacetabular Impingement
Interventions
Spatiotemporal walking assessments are performed using the Gait Analyzer app (version 0.9.95.0) on a smartphone. Participants who can walk independently without assistance walk a 25-meter path at their normal speed, with the smartphone securely attached to their body above the third lumbar vertebra using a belt. The app records gait velocity, cadence, step time, step length, and vertical center of mass for all participants.
Eligibility Criteria
Patients scheduled for hip arthroscopy due to Femoroacetabular impingement syndrome at the Department of Orthopedics and Traumatology, Gazi University Faculty of Medicine, along with a healthy control group matched for age and gender, will be included in the study.
You may qualify if:
- Patients with femoroacetabular impingement scheduled for hip arthroscopy
You may not qualify if:
- Severe hip osteoarthritis
- Hip dysplasia
- Previous ipsilateral and/or contralateral hip surgery,
- Any orthopedic or neurologic pathology that may affect gait patterns
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Gazi Universitylead
Study Sites (1)
Gazi University Hospital
Ankara, 06500, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Ulunay Kanatlı, Professor
Gazi University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 29, 2024
First Posted
August 2, 2024
Study Start
January 1, 2022
Primary Completion
September 30, 2024
Study Completion
December 30, 2024
Last Updated
August 2, 2024
Record last verified: 2024-07